Fair Pricing Coalition Highlights Major Barriers to Life-Saving Treatment in Affordable Care Act Health Insurance Marketplace Plans
New Report Offers Short- and Long-Term Solutions to Minimize Out-of-Pocket Expenses and Maximize Access to Treatment for All Qualified Health Plan Beneficiaries Living With HIV and/or Hepatitis C
February 6, 2014
Discriminatory practices by Qualified Health Plans (QHPs) in the health insurance marketplaces, exorbitant drug pricing by the pharmaceutical industry, and a lack of clear guidance from the federal government regarding the legality of co-payment assistance programs for QHP beneficiaries are proving to be major barriers to affordable treatment for HIV and hepatitis C, according to a new policy guide produced by the Fair Pricing Coalition (FPC).
"The QHPs mandated by the Affordable Care Act are good news for many people living with HIV and/or hepatitis C, as it means they can't be denied health insurance, because of pre-existing conditions," explained FPC Co-Chair Lynda Dee. "This ensures the provision of essential health benefits, including important primary care services, access to specialists, and prescription drug benefits."
"However, many plans are proving financially disastrous for people living HIV, hepatitis C, and other chronic diseases," Dee added. "This situation is made worse by high drug prices being set and increased annually by manufacturers, along with an inexcusable lack of direction from the U.S. Department of Health and Human Services regarding co-pay assistance programs for people receiving care under ACA-mandated plans."
According to FPC's policy guide, Health Insurance Marketplace Plans and People Living With HIV and/or Viral Hepatitis: The Success of the Affordable Care Act Requires Fair Drug Pricing and Access, numerous drug pricing and access issues are becoming increasingly apparent:
"These are major barriers to life-saving treatment, when in fact we need to be making access to affordable treatment as easy as possible," said Tim Horn, an FPC member. "Nationally, only 25 percent of people living with HIV are receiving HIV treatment and keeping the virus in their blood in check. This is essential in terms of protecting their own health and preventing ongoing transmission of the virus. We need to get more people on treatment, not fewer, which won't be possible if they cannot afford their costly medications."
Among the possible short- and long-term solutions offered by the FPC:
"The problems outlined in the policy report are not insurmountable," said Dee. "The FPC believes that the Affordable Care Act, while not perfect, has tremendous potential to redress disparities for U.S. residents whose access to healthcare has previously been at the whim of conflicting political and economic forces. This applies not only to HIV/AIDS and viral hepatitis, but also to many other chronic, debilitating, and costly health challenges beyond the capacity of individuals to manage on their own."
The FPC supports urgent attention to these matters for all U.S. residents at this moment of new hope for achieving universal, affordable, quality health care.
This article was provided by Fair Pricing Coalition. Visit FPC's website to find out more about their activities and publications.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)